Patents by Inventor Wenjun GENG

Wenjun GENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALS OF QUINOLONE DERIVATIVES
    Publication number: 20220098172
    Abstract: The present application relates to the field of medicine, and relates to crystals of quinoline derivatives, and in particular, to crystals of a quinoline derivative anhydride and a solvate, as well as a method for preparing the crystals, pharmaceutical compositions containing the crystals, and a use thereof in the field of medicine. The present application further provides a preparation method therefor, which has a high yield, has mild crystallization conditions, is suitable for industrial production, and may better meet the needs of the pharmaceutical industry.
    Type: Application
    Filed: July 31, 2020
    Publication date: March 31, 2022
    Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Xiquan ZHANG, Shanchun WANG, Wenjun GENG, Yanlong LIU, Huihui ZHANG, Fei LIU, Shanliang ZHU, Xinlu LI, Rui ZHAO, Hongmei GU
  • Use of quinoline derivatives for treating oesophageal cancer and treatment method, pharmaceutical composition and kit thereof
    Patent number: 10561647
    Abstract: Provided in the present invention are a use of quinoline derivatives for treating oesophageal cancer and a treatment method, a pharmaceutical composition and a kit thereof. The 1-[[[4-(4-fluoro-2-methyl-1H-indole-5-yl)oxy-6-methoxyquinoline-7-yl]oxy]methyl]cyclopropylamine provided by the present invention can effectively treat oesophageal cancer, and reduce the sum of the diameters of patient's target lesions.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: February 18, 2020
    Assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Inventors: Xunqiang Wang, Ling Yang, Zhongnan Xu, Xiangjian Wang, Wenjun Geng
  • Use Of Quinoline Derivatives For Treating Oesophageal Cancer And Treatment Method, Pharmaceutical Composition And Kit Thereof
    Publication number: 20190022082
    Abstract: Provided in the present invention are a use of quinoline derivatives for treating oesophageal cancer and a treatment method, a pharmaceutical composition and a kit thereof. The 1-[[[4-(4-fluoro-2-methyl-1H-indole-5-yl)oxy-6-methoxyquinoline-7-yl]oxy]methyl]cyclopropylamine provided by the present invention can effectively treat oesophageal cancer, and reduce the sum of the diameters of patient's target lesions.
    Type: Application
    Filed: January 6, 2017
    Publication date: January 24, 2019
    Inventors: Xunqiang WANG, Ling YANG, Zhongnan XU, Xiangjian WANG, Wenjun GENG